Innate Pharma S.A. ADR (IPHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IPHA | CBIO | KLRS | ||
| Company | Innate Pharma S.A. ADR | Crescent Biopharma Inc | Kalaris Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.8000 | 11.75 | 8.38 | ||
| High | 1.8000 | 11.90 | 8.89 | ||
| Low | 1.7001 | 11.40 | 8.31 | ||
| Latest | 1.7500 | 11.86 | 8.44 | ||
| Change | +0.0100 | +0.26 | +0.06 | ||
| % Change | +0.57% | +2.24% | +0.72% | ||
| Volume | 15,300 | 51,100 | 119,300 | ||
| 20-Day Average Volume | 27,205 | 239,215 | 182,660 | ||
| Previous Close | 1.7400 | 11.60 | 8.38 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.8149 | 12.90 | 8.35 | ||
| 20-Day Raw Stochastic | 34.29% | 9.29% | 47.48% | ||
| 20-Day Relative Strength | 43.82 | 43.14 | 55.94 | ||
| Weighted Alpha | -12.12 | -55.98 | -7.94 | ||
| Today's Opinion | 100% Sell | 88% Sell | 100% Buy | ||
| Previous Opinion | 100% Sell | 72% Sell | 100% Buy | ||
| Last Month's Opinion | 80% Sell | 8% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.57% since 12/23/25 | -2.15% since 12/23/25 | -12.63% since 12/23/25 | ||
| Low | 1.6300 on 12/26/25 | 11.40 on 12/31/25 | 8.31 on 12/31/25 | ||
| High | 1.8300 on 12/30/25 | 12.61 on 12/30/25 | 10.20 on 12/26/25 | ||
| 1-Month | |||||
| %Chg | -10.26% since 11/28/25 | -21.20% since 11/28/25 | +35.26% since 11/28/25 | ||
| Low | 1.6300 on 12/26/25 | 11.40 on 12/31/25 | 5.10 on 12/02/25 | ||
| High | 2.0100 on 12/01/25 | 16.35 on 12/04/25 | 11.88 on 12/18/25 | ||
| 3-Month | |||||
| %Chg | -9.33% since 09/30/25 | -0.25% since 09/30/25 | +46.02% since 09/30/25 | ||
| Low | 1.6300 on 12/26/25 | 9.81 on 10/14/25 | 4.27 on 10/22/25 | ||
| High | 2.4250 on 11/10/25 | 16.35 on 12/04/25 | 11.88 on 12/18/25 | ||
| 6-Month | |||||
| %Chg | -3.58% since 06/30/25 | -26.52% since 06/30/25 | +216.10% since 06/30/25 | ||
| Low | 1.6300 on 12/26/25 | 9.81 on 10/14/25 | 2.14 on 08/14/25 | ||
| High | 2.6300 on 07/30/25 | 17.39 on 07/02/25 | 11.88 on 12/18/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 160,409 | 161,159 | 156,723 | ||
| Shares Outstanding, K | 92,189 | 13,893 | 18,702 | ||
| Annual Sales | 21,770,000 | 794,000 | 0 | ||
| Annual Net Income | -53,530,000 | -37,880,000 | -58,770,000 | ||
| Last Quarter Sales | N/A | 0 | 0 | ||
| Last Quarter Net Income | N/A | -24,610,000 | -11,890,000 | ||
| 60-Month Beta | -0.08 | 1.32 | -0.04 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.27 on 11/06/25 | -0.64 on 11/12/25 | ||
| Latest Earnings Date | 11/13/25 | 02/12/26 | 03/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | 08/20/15 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||